KPMG's latest report on China's life science sector notes that the country is set to become a crucial player in the life science and healthcare industry. Within a decade it is expected to become a global leader in drug discovery and innovation.
This report makes a compelling read for any organisation that is either planning or implementing a cloud strategy, and provides some practical and actionable advice for enterprises and their executives.
China alert - Issue 20, December 2010
Chinese authorities have relaxed the recognition criteria for advanced technology service enterprises (ATSE). With the promulgation of Circular 65, Circular 63 has been abolished starting 1 July 2010.
Related links
Subscribe to receive email alerts or e-Newsletters from KPMG China when new updates are available.